Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT)

Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06555861

Acronym

MUMOFRAT retro

Enrollment

Registered

2024-08-15

Start date

2019-01-07

Completion date

2019-02-06

Last updated

2024-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Identify FDG PET/CT Parameters Predictive of Local Control

Keywords

PET/CT, Radiomics, Early-stage NSCLC, Stereotactic radiotherapy

Brief summary

The aim of this retrospective multicentric study was to develop and evaluate a prognostic FDG PET/CT radiomics signature in early-stage non-small cell lung cancer (NSCLC) patients treated with stereotactic radiotherapy (SBRT).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* NSCLC stage I-II treated by SBRT * PET/CT imaging performed within 60 days of SBRT

Exclusion criteria

* Lack of follow-up * Refusal of consent

Design outcomes

Primary

Measure	Time frame	Description
Local Recurrence	Time-to-Event measures up to 5 years	accuracy

Secondary

Measure	Time frame	Description
Cancer specific survival	Time-to-Event measures up to 5 years	accuracy
Distant metastasis free survival	Time-to-Event measures up to 5 years	accuracy
Recurrence free survival	Time-to-Event measures up to 5 years	accuracy
Overall survival	Time-to-Event measures up to 5 years	accuracy

Countries

France

Outcome results